Breakthrough Alzheimer’s Drug Could Mean Hope for Those with the Disease

By Pete Lane, 9:00 am on

Alzheimer’s disease has traditionally been treated with drugs that are classified as acetylcholinesterase inhibitors, which maintain some balance in nerve cells. Some examples of these medications include donepezil and rivastigmine. Recently, scientists around the world have discovered a new type of drug that is not at all related to acetylcholinesterase inhibitors. Nonetheless, it’s bringing hope to Alzheimer’s caregivers in Centennial, CO, and the seniors they care for.

Aducanumab is a complex compound that essentially stands in its own class of treatment for Alzheimer’s disease. In theory, this drug can reduce the amount of amyloid beta proteins in the brain. These proteins can be very toxic when they reach abnormal levels. Amyloid beta proteins can clump together to form a type of plaque that can clog the nervous system in the brain. A good comparison would be plaque that builds up in the arteries and increases the risk of stroke. Scientists believe that an appropriate dose of aducanumab can slow down the progression of Alzheimer’s disease. More specifically, this drug can improve memory function that is hindered by the accumulation of amyloid beta substances. 

In some recent experiments, aducanumab was given to participants who have already been diagnosed with an early stage of Alzheimer’s disease. After taking the drug for several months, the individuals were thoroughly examined for any signs of improvement. For example, PET scans were utilized to generate detailed images of the brains of the participants. Additionally, other types of standard tests were used to check for improvement in cognitive abilities. The Mini Mental State Examination provided an accurate measurement of any improvement in memory and other basic learning skills. 

Biogen is taking a leading role in bringing aducanumab to the healthcare marketplace around the world. This American biotechnology enterprise hopes to provide reliable research data on this drug that can drastically revolutionize treatment for Alzheimer’s disease. After aducanumab was mentioned at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases, many scientists worldwide are optimistic about the future of dementia treatment.

Learn more about aducanumab and stay up to date on the latest Alzheimer’s news by reaching out to Home Care Assistance of Centennial, Colorado. We are the leading provider of home care Centennial, Colorado, families trust to help local seniors age in place despite cognitive disorders like Alzheimer’s and dementia. Contact a reliable Care Manager at 303.957.3100 today to learn more about our cognitive care services and how they benefit our clients.

Bootstrap 101 Template